EE9500049A - Bensoksasolüül- ja bensotiasolüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimitena ja nimetatud ühendeid sisaldavad ravimid - Google Patents
Bensoksasolüül- ja bensotiasolüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimitena ja nimetatud ühendeid sisaldavad ravimidInfo
- Publication number
- EE9500049A EE9500049A EE9500049A EE9500049A EE9500049A EE 9500049 A EE9500049 A EE 9500049A EE 9500049 A EE9500049 A EE 9500049A EE 9500049 A EE9500049 A EE 9500049A EE 9500049 A EE9500049 A EE 9500049A
- Authority
- EE
- Estonia
- Prior art keywords
- alkyl
- substd
- opt
- alkoxy
- acyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4427475 | 1994-08-03 | ||
DE19514313A DE19514313A1 (de) | 1994-08-03 | 1995-04-18 | Benzoxazolyl- und Benzothiazolyloxazolidinone |
Publications (1)
Publication Number | Publication Date |
---|---|
EE9500049A true EE9500049A (et) | 1996-02-15 |
Family
ID=25938925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9500049A EE9500049A (et) | 1994-08-03 | 1995-08-02 | Bensoksasolüül- ja bensotiasolüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimitena ja nimetatud ühendeid sisaldavad ravimid |
Country Status (30)
Country | Link |
---|---|
US (1) | US5529998A (fr) |
EP (1) | EP0697412B1 (fr) |
JP (1) | JPH0881463A (fr) |
KR (1) | KR960007585A (fr) |
CN (1) | CN1122803A (fr) |
AT (1) | ATE188698T1 (fr) |
AU (1) | AU698939B2 (fr) |
BG (1) | BG62404B1 (fr) |
CA (1) | CA2155092A1 (fr) |
CO (1) | CO4410392A1 (fr) |
CZ (1) | CZ198895A3 (fr) |
DE (2) | DE19514313A1 (fr) |
DZ (1) | DZ1920A1 (fr) |
EE (1) | EE9500049A (fr) |
FI (1) | FI953665A (fr) |
HR (1) | HRP950428A2 (fr) |
HU (1) | HUT75037A (fr) |
IL (1) | IL114784A (fr) |
MA (1) | MA23638A1 (fr) |
NO (1) | NO305701B1 (fr) |
NZ (1) | NZ272674A (fr) |
PE (1) | PE2796A1 (fr) |
PL (1) | PL309848A1 (fr) |
RO (1) | RO115263B1 (fr) |
SK (1) | SK97495A3 (fr) |
SV (1) | SV1995000045A (fr) |
TN (1) | TNSN95088A1 (fr) |
TW (1) | TW352386B (fr) |
YU (1) | YU51095A (fr) |
ZA (1) | ZA956445B (fr) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP960159A2 (en) * | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
GB9601666D0 (en) * | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
HRP970049A2 (en) * | 1996-02-06 | 1998-04-30 | Bayer Ag | New heteroaryl oxazolidinones |
GB9702213D0 (en) * | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
GB9609919D0 (en) | 1996-05-11 | 1996-07-17 | Zeneca Ltd | Chemical compounds |
GB9717807D0 (en) * | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
GB9717804D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
GB9725244D0 (en) | 1997-11-29 | 1998-01-28 | Zeneca Ltd | Chemical compounds |
NZ505902A (en) | 1998-01-23 | 2003-08-29 | Upjohn Co | Oxazolidinone compounds useful as antimicrobial agents and combinatorial libraries |
CN1311787A (zh) | 1998-06-05 | 2001-09-05 | 阿斯特拉曾尼卡有限公司 | 噁唑烷酮衍生物、其制备方法以及含有它们的药物组合物 |
GB9815880D0 (en) | 1998-07-21 | 1998-09-16 | Pfizer Ltd | Heterocycles |
US6420349B1 (en) | 1998-08-24 | 2002-07-16 | Bristol-Myers Squibb Company | Isoxazolinone antibacterial agents |
AU1045300A (en) * | 1998-11-17 | 2000-06-05 | Bayer Aktiengesellschaft | Novel heterocyclyl-substituted oxazolidone derivatives |
JP2002535680A (ja) | 1999-01-27 | 2002-10-22 | ファルマシア・アンド・アップジョン・カンパニー | 延長因子p活性モジュレーターのアッセイ方法 |
GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
US6514529B2 (en) | 2000-03-22 | 2003-02-04 | Pharmacia & Upjohn Company | Oxazolidinone tablet formulation |
MY127336A (en) * | 2000-03-22 | 2006-11-30 | Upjohn Co | Container for linezolid iv solution |
GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
US6465456B2 (en) | 2000-06-29 | 2002-10-15 | Bristol-Myers Squibb Company | Isoxazolinone antibacterial agents |
WO2002002095A2 (fr) | 2000-06-30 | 2002-01-10 | Pharmacia & Upjohn Company | Composition et techniques de traitement d'infections bacteriennes |
KR100944645B1 (ko) * | 2000-12-15 | 2010-03-04 | 버텍스 파마슈티칼스 인코포레이티드 | 자이라제 억제제 및 이를 포함하는 약제학적 조성물 |
WO2002059116A2 (fr) | 2000-12-21 | 2002-08-01 | Pharmacia & Upjohn Company | Derives antimicrobiens de la quinolone et leur utilisation pour le traitement d'infections bacteriennes |
US7141588B2 (en) * | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
AR038536A1 (es) * | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
NZ535648A (en) * | 2002-03-29 | 2007-05-31 | Pharmacia & Upjohn Co Llc | Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections |
KR101052433B1 (ko) | 2002-06-13 | 2011-07-29 | 버텍스 파마슈티칼스 인코포레이티드 | 자이라제 및/또는 토포이소머라제 ⅳ 억제제로서의 2-우레이도-6-헤테로아릴-3h-벤조이미다졸-4-카복실산 유도체 및 이를 포함하는 세균 감염 치료용 약제학적 조성물 |
CA2491287A1 (fr) * | 2002-08-12 | 2004-02-19 | Pharmacia & Upjohn Company | N-aryl-2-oxazolidinones et leurs derives |
WO2004026848A1 (fr) * | 2002-09-20 | 2004-04-01 | Lupin Limited | Derives d'oxazolidinone, leur procede de preparation et leur utilisation comme agents antimycobacterients |
ES2271660T3 (es) * | 2002-11-21 | 2007-04-16 | PHARMACIA & UPJOHN COMPANY LLC | Derivados de n-(4-piperazin-1-il)-fenil-2-oxazolidinona-5-carboxamida y compuestos relacionados como agentes antibacterianos. |
US7582635B2 (en) | 2002-12-24 | 2009-09-01 | Purdue Pharma, L.P. | Therapeutic agents useful for treating pain |
US7582641B2 (en) | 2003-01-31 | 2009-09-01 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US8193352B2 (en) * | 2003-01-31 | 2012-06-05 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US7569591B2 (en) * | 2003-01-31 | 2009-08-04 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
AR042956A1 (es) | 2003-01-31 | 2005-07-13 | Vertex Pharma | Inhibidores de girasa y usos de los mismos |
US7618974B2 (en) * | 2003-01-31 | 2009-11-17 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
JP2006516991A (ja) * | 2003-02-07 | 2006-07-13 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 抗菌剤 |
MXPA05007937A (es) * | 2003-02-07 | 2005-09-30 | Warner Lambert Co | Agentes antibacterianos. |
US7012088B2 (en) * | 2003-02-24 | 2006-03-14 | Pharmacia & Upjohn Company | Indolone oxazolidinones and derivatives thereof |
US20040204463A1 (en) * | 2003-04-01 | 2004-10-14 | Harris Christina Renee | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
CA2536480A1 (fr) * | 2003-08-25 | 2005-03-03 | Warner-Lambert Company Llc | Nouveaux composes d'aryloxazolidinone antimicrobiens |
US7304050B2 (en) * | 2003-09-16 | 2007-12-04 | Pfizer Inc. | Antibacterial agents |
US20060004090A1 (en) * | 2004-07-01 | 2006-01-05 | Roberts William J | Forskolin compositions and methods for administration |
CA2637811A1 (fr) * | 2006-02-01 | 2007-08-09 | Pfizer Products Inc. | Agents antibacteriens |
TW200804358A (en) | 2006-03-31 | 2008-01-16 | Res Found Itsuu Lab | Novel compound having heterocycle |
CA2685121A1 (fr) * | 2007-04-27 | 2008-11-06 | Purdue Pharma L.P. | Agents therapeutiques utiles pour traiter la douleur |
CA2833209C (fr) * | 2007-04-27 | 2016-06-28 | Purdue Pharma L.P. | Composes de piperidine et piperazine en tant qu'antagonistes de trpv1 |
JPWO2009044777A1 (ja) * | 2007-10-02 | 2011-02-10 | 財団法人乙卯研究所 | 7員ヘテロ環を有するオキサゾリジノン誘導体 |
EP2254887B9 (fr) * | 2008-02-22 | 2013-05-29 | Actelion Pharmaceuticals Ltd. | Dérivés d'oxazolidinone |
US8703962B2 (en) * | 2008-10-24 | 2014-04-22 | Purdue Pharma L.P. | Monocyclic compounds and their use as TRPV1 ligands |
US8759362B2 (en) * | 2008-10-24 | 2014-06-24 | Purdue Pharma L.P. | Bicycloheteroaryl compounds and their use as TRPV1 ligands |
CA2824403C (fr) | 2011-01-14 | 2019-09-24 | Vertex Pharmaceuticals Incorporated | Formes solides d'inhibiteur de gyrase (r)-1-ethyle-3-[6-fluoro-5-[2-(1-hydroxy-1-methyle-ethyle) pyrimidine-5-yl]-7-(tetrahydrofurane-2-yl)-1h-benzimidazol-2-yl]uree |
EP2663558A1 (fr) | 2011-01-14 | 2013-11-20 | Vertex Pharmaceuticals Incorporated | Formes solides de l'inhibiteur de gyrase, la (r)-1-éthyl-3-[5-[2-{1-hydroxy-1-méthyl-éthyl}pyrimidin-5-yl]-7-(tétrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urée |
JP6006235B2 (ja) | 2011-01-14 | 2016-10-12 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | ジャイレースおよびトポイソメラーゼiv阻害剤を作製するプロセス |
WO2012097269A1 (fr) | 2011-01-14 | 2012-07-19 | Vertex Pharmaceuticals Incorporated | Inhibiteurs de pyrimidine gyrase et topoïsomérase iv |
CN103702994B (zh) | 2011-06-20 | 2016-03-23 | 沃泰克斯药物股份有限公司 | 旋转酶和拓扑异构酶抑制剂的磷酸酯 |
EP2723732B1 (fr) | 2011-06-22 | 2017-01-18 | Purdue Pharma LP | Antagonistes de trpv1 comprenant un substituant dihydroxy et leurs utilisations |
WO2013021276A1 (fr) | 2011-08-10 | 2013-02-14 | Purdue Pharma L.P. | Antagonistes du trpv1 comprenant un substituant dihydroxy et leurs utilisations |
TWI595002B (zh) | 2012-07-18 | 2017-08-11 | 思沛羅三南公司 | (R)-2-(5-(2-(3-乙基脲基)-6-氟-7-(四氫呋喃-2-基)-1H-苯并[d]咪唑-5-基)嘧啶-2-基)丙烷-2-基磷酸二氫鹽之固體形式及其鹽 |
US9572809B2 (en) | 2012-07-18 | 2017-02-21 | Spero Trinem, Inc. | Combination therapy to treat Mycobacterium diseases |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4705799A (en) | 1983-06-07 | 1987-11-10 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents |
GB8504871D0 (en) * | 1985-02-26 | 1985-03-27 | Ici Plc | Heterocyclic compounds |
US4801600A (en) | 1987-10-09 | 1989-01-31 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
US4965268A (en) | 1987-10-09 | 1990-10-23 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
US4921869A (en) | 1987-10-09 | 1990-05-01 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
CA1320730C (fr) | 1987-10-16 | 1993-07-27 | The Du Pont Merck Pharmaceutical Company | Derives d'aminomethyloxooxazolidinylaroylbenzene, agents antibacteriens |
US5254577A (en) | 1988-07-29 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
JP2865211B2 (ja) * | 1988-09-15 | 1999-03-08 | ファルマシア・アンド・アップジョン・カンパニー | 5’―インドリニル―5β―アミドメチルオキサゾリジン―2―オン類、3―(縮合環置換)フェニル―5β―アミドメチルオキサゾリジン―2―オン類および3―(窒素原子置換)フェニル―5β―アミドメチルオキサゾリジン―2―オン類 |
JP2669579B2 (ja) * | 1991-10-23 | 1997-10-29 | エーザイ株式会社 | オキサゾリドン誘導体 |
EP0610265B1 (fr) * | 1991-11-01 | 1996-12-27 | PHARMACIA & UPJOHN COMPANY | Aryl- et heteroarylphenyloxazolidinones substituees, utilisees comme agents antibacteriens |
-
1995
- 1995-04-18 DE DE19514313A patent/DE19514313A1/de not_active Withdrawn
- 1995-06-14 TN TNTNSN95088A patent/TNSN95088A1/fr unknown
- 1995-07-18 RO RO95-01322A patent/RO115263B1/ro unknown
- 1995-07-21 AT AT95111477T patent/ATE188698T1/de active
- 1995-07-21 EP EP95111477A patent/EP0697412B1/fr not_active Expired - Lifetime
- 1995-07-21 DE DE59507595T patent/DE59507595D1/de not_active Expired - Fee Related
- 1995-07-25 HR HR19514313.2A patent/HRP950428A2/hr not_active Application Discontinuation
- 1995-07-27 AU AU27230/95A patent/AU698939B2/en not_active Ceased
- 1995-07-27 US US08/508,245 patent/US5529998A/en not_active Expired - Fee Related
- 1995-07-28 NZ NZ272674A patent/NZ272674A/en unknown
- 1995-07-28 SV SV1995000045A patent/SV1995000045A/es unknown
- 1995-07-28 JP JP7211265A patent/JPH0881463A/ja active Pending
- 1995-07-31 IL IL11478495A patent/IL114784A/xx active IP Right Grant
- 1995-07-31 CA CA002155092A patent/CA2155092A1/fr not_active Abandoned
- 1995-08-01 PL PL95309848A patent/PL309848A1/xx unknown
- 1995-08-01 BG BG99833A patent/BG62404B1/bg unknown
- 1995-08-01 FI FI953665A patent/FI953665A/fi unknown
- 1995-08-02 HU HU9502295A patent/HUT75037A/hu unknown
- 1995-08-02 NO NO953045A patent/NO305701B1/no unknown
- 1995-08-02 DZ DZ950098A patent/DZ1920A1/fr active
- 1995-08-02 KR KR1019950023799A patent/KR960007585A/ko not_active Application Discontinuation
- 1995-08-02 EE EE9500049A patent/EE9500049A/xx unknown
- 1995-08-02 PE PE1995275165A patent/PE2796A1/es not_active Application Discontinuation
- 1995-08-02 SK SK974-95A patent/SK97495A3/sk unknown
- 1995-08-02 CZ CZ951988A patent/CZ198895A3/cs unknown
- 1995-08-02 ZA ZA956445A patent/ZA956445B/xx unknown
- 1995-08-03 CO CO95034777A patent/CO4410392A1/es unknown
- 1995-08-03 CN CN95115330A patent/CN1122803A/zh active Pending
- 1995-08-03 TW TW084108069A patent/TW352386B/zh active
- 1995-08-03 MA MA23979A patent/MA23638A1/fr unknown
- 1995-08-11 YU YU51095A patent/YU51095A/sh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE9500049A (et) | Bensoksasolüül- ja bensotiasolüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimitena ja nimetatud ühendeid sisaldavad ravimid | |
BR9404831A (pt) | Composto,formulação farmacêutica e processo de preparação de um composto | |
DZ1467A1 (fr) | Dérivés d'acides amines. | |
EE9600043A (et) | Heteroaatomit sisaldavad bensotsüklopentaanoksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
NO305206B1 (no) | Oksazolidinonkarboksylsyrederivater, farmas°ytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler | |
NO306991B1 (no) | Alkenylbenzoylguanidinderivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler | |
HUT76480A (en) | Alkyl-5-methyl-sulphonyl-benzoyl-guanidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
IL120863A0 (en) | Sulfur-containing heterocyclic bradykinin antagonists process for their preparation and their use | |
IL119054A (en) | Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them | |
NO307998B1 (no) | Cykloheksadienderivater, fremgangsmÕte for fremstilling av forbindelsene, anvendelse av forbindelsene for fremstilling av legemidler samt de derved oppnÕdde legemidlene |